281 related articles for article (PubMed ID: 28863192)
41. Mechanisms of Ca2+-dependent calcineurin activation in mechanical stretch-induced hypertrophy.
Zobel C; Rana OR; Saygili E; Bölck B; Saygili E; Diedrichs H; Reuter H; Frank K; Müller-Ehmsen J; Pfitzer G; Schwinger RH
Cardiology; 2007; 107(4):281-90. PubMed ID: 17264507
[TBL] [Abstract][Full Text] [Related]
42. Sustained increased CaMKII phosphorylation is involved in the impaired regression of isoproterenol-induced cardiac hypertrophy in rats.
Li J; Gao Q; Wang S; Kang Z; Li Z; Lei S; Sun X; Zhao M; Chen X; Jiao G; Hu H; Hao L
J Pharmacol Sci; 2020 Sep; 144(1):30-42. PubMed ID: 32665128
[TBL] [Abstract][Full Text] [Related]
43. Betulinic Acid Protects DOX-Triggered Cardiomyocyte Hypertrophy Response through the GATA-4/Calcineurin/NFAT Pathway.
Yoon JJ; Son CO; Kim HY; Han BH; Lee YJ; Lee HS; Kang DG
Molecules; 2020 Dec; 26(1):. PubMed ID: 33374365
[TBL] [Abstract][Full Text] [Related]
44. Inhibition of calcineurin-NFAT hypertrophy signaling by cGMP-dependent protein kinase type I in cardiac myocytes.
Fiedler B; Lohmann SM; Smolenski A; Linnemuller S; Pieske B; Schroder F; Molkentin JD; Drexler H; Wollert KC
Proc Natl Acad Sci U S A; 2002 Aug; 99(17):11363-8. PubMed ID: 12177418
[TBL] [Abstract][Full Text] [Related]
45. Estrogen inhibits cardiomyocyte hypertrophy in vitro. Antagonism of calcineurin-related hypertrophy through induction of MCIP1.
Pedram A; Razandi M; Aitkenhead M; Levin ER
J Biol Chem; 2005 Jul; 280(28):26339-48. PubMed ID: 15899894
[TBL] [Abstract][Full Text] [Related]
46. Spironolactone Inhibits Cardiomyocyte Hypertrophy by Regulating the Ca
Wang X; Zhang W; Na J; Huo Y; Wang Y; Liu K
J Healthc Eng; 2021; 2021():3843830. PubMed ID: 34956570
[TBL] [Abstract][Full Text] [Related]
47. Calcium influx through Cav1.2 is a proximal signal for pathological cardiomyocyte hypertrophy.
Chen X; Nakayama H; Zhang X; Ai X; Harris DM; Tang M; Zhang H; Szeto C; Stockbower K; Berretta RM; Eckhart AD; Koch WJ; Molkentin JD; Houser SR
J Mol Cell Cardiol; 2011 Mar; 50(3):460-70. PubMed ID: 21111744
[TBL] [Abstract][Full Text] [Related]
48. NAKα2 inhibits fibrosis formation and protects against cardiomyocyte hypertrophy by suppressing hypertrophy associated molecules and activating LTCC/NCX signaling pathway.
Song SS; Tang G; Tang LX; Si LY; Xiong W
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(7):3021-3033. PubMed ID: 31002153
[TBL] [Abstract][Full Text] [Related]
49. Activation of transient receptor potential vanilloid 3 channel (TRPV3) aggravated pathological cardiac hypertrophy via calcineurin/NFATc3 pathway in rats.
Zhang Q; Qi H; Cao Y; Shi P; Song C; Ba L; Chen Y; Gao J; Li S; Li B; Sun H
J Cell Mol Med; 2018 Dec; 22(12):6055-6067. PubMed ID: 30299584
[TBL] [Abstract][Full Text] [Related]
50. The role of Ca2+/calmodulin-dependent protein kinase II and calcineurin in TNF-α-induced myocardial hypertrophy.
Wang GJ; Wang HX; Yao YS; Guo LY; Liu P
Braz J Med Biol Res; 2012 Nov; 45(11):1045-51. PubMed ID: 22832601
[TBL] [Abstract][Full Text] [Related]
51. Imatinib activates pathological hypertrophy by altering myocyte calcium regulation.
Barr LA; Makarewich CA; Berretta RM; Gao H; Troupes CD; Woitek F; Recchia F; Kubo H; Force T; Houser SR
Clin Transl Sci; 2014 Oct; 7(5):360-7. PubMed ID: 24931551
[TBL] [Abstract][Full Text] [Related]
52. PICOT attenuates cardiac hypertrophy by disrupting calcineurin-NFAT signaling.
Jeong D; Kim JM; Cha H; Oh JG; Park J; Yun SH; Ju ES; Jeon ES; Hajjar RJ; Park WJ
Circ Res; 2008 Mar; 102(6):711-9. PubMed ID: 18258855
[TBL] [Abstract][Full Text] [Related]
53. Enhanced Ca2+ channel currents in cardiac hypertrophy induced by activation of calcineurin-dependent pathway.
Yatani A; Honda R; Tymitz KM; Lalli MJ; Molkentin JD
J Mol Cell Cardiol; 2001 Feb; 33(2):249-59. PubMed ID: 11162130
[TBL] [Abstract][Full Text] [Related]
54. Calcineurin-NFATc regulates type 2 inositol 1,4,5-trisphosphate receptor (InsP3R2) expression during cardiac remodeling.
Sankar N; deTombe PP; Mignery GA
J Biol Chem; 2014 Feb; 289(9):6188-98. PubMed ID: 24415751
[TBL] [Abstract][Full Text] [Related]
55. Kv4.3 expression abrogates and reverses norepinephrine-induced myocyte hypertrophy by CaMKII inhibition.
Wang Y; Keskanokwong T; Cheng J
J Mol Cell Cardiol; 2019 Jan; 126():77-85. PubMed ID: 30462989
[TBL] [Abstract][Full Text] [Related]
56. NFAT-dependent excitation-transcription coupling in heart.
Santana LF
Circ Res; 2008 Sep; 103(7):681-3. PubMed ID: 18818410
[No Abstract] [Full Text] [Related]
57. Neuronal calcium sensor-1 promotes immature heart function and hypertrophy by enhancing Ca2+ signals.
Nakamura TY; Jeromin A; Mikoshiba K; Wakabayashi S
Circ Res; 2011 Aug; 109(5):512-23. PubMed ID: 21737792
[TBL] [Abstract][Full Text] [Related]
58. T-type Ca2+ channel blockers prevent cardiac cell hypertrophy through an inhibition of calcineurin-NFAT3 activation as well as L-type Ca2+ channel blockers.
Horiba M; Muto T; Ueda N; Opthof T; Miwa K; Hojo M; Lee JK; Kamiya K; Kodama I; Yasui K
Life Sci; 2008 Mar; 82(11-12):554-60. PubMed ID: 18275974
[TBL] [Abstract][Full Text] [Related]
59. Effect of distinct sources of Ca(2+) on cardiac hypertrophy in cardiomyocytes.
Xu H; Zhang Y; Sun J; Wei J; Sun L; Zhang J
Exp Biol Med (Maywood); 2012 Mar; 237(3):271-8. PubMed ID: 22345300
[TBL] [Abstract][Full Text] [Related]
60. Interference of antihypertrophic molecules and signaling pathways with the Ca2+-calcineurin-NFAT cascade in cardiac myocytes.
Fiedler B; Wollert KC
Cardiovasc Res; 2004 Aug; 63(3):450-7. PubMed ID: 15276470
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
